Insights from 2023 ASH Annual Meeting
ASH 2023 Insights: "MATTERHORN Study - Efficacy & Safety of Roxadustat for Treatment of Anemia in Patients With LR-MDS With Low RBC Transfusion Burden"
By
Insights from 2023 ASH Annual Meeting
FEATURING
Moshe Mittelman
By
Insights from 2023 ASH Annual Meeting
FEATURING
Moshe Mittelman
Login to view comments.
Click here to Login